SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $321.99 million. The enterprise value is $348.73 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.57 million shares outstanding. The number of shares has increased by 146.84% in one year.
| Current Share Class | 8.57M |
| Shares Outstanding | 8.57M |
| Shares Change (YoY) | +146.84% |
| Shares Change (QoQ) | +7.26% |
| Owned by Insiders (%) | 5.88% |
| Owned by Institutions (%) | 18.22% |
| Float | 4.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 78.29 |
| PS Ratio | 7.30 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 219.66 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.90 |
| EV / EBITDA | 41.13 |
| EV / EBIT | 47.52 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.43
| Current Ratio | 0.43 |
| Quick Ratio | 0.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.27 |
| Debt / FCF | n/a |
| Interest Coverage | 0.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 16.97% |
| Return on Invested Capital (ROIC) | 140.45% |
| Return on Capital Employed (ROCE) | -54.54% |
| Revenue Per Employee | $852,000 |
| Profits Per Employee | -$826,652 |
| Employee Count | 46 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, SANUWAVE Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +608.23% in the last 52 weeks. The beta is 1.29, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +608.23% |
| 50-Day Moving Average | 34.17 |
| 200-Day Moving Average | 28.45 |
| Relative Strength Index (RSI) | 57.66 |
| Average Volume (20 Days) | 50,795 |
Short Selling Information
The latest short interest is 467,692, so 5.46% of the outstanding shares have been sold short.
| Short Interest | 467,692 |
| Short Previous Month | 483,136 |
| Short % of Shares Out | 5.46% |
| Short % of Float | 9.50% |
| Short Ratio (days to cover) | 7.75 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $39.19 million and -$38.03 million in losses. Loss per share was -$5.30.
| Revenue | 39.19M |
| Gross Profit | 30.45M |
| Operating Income | 7.34M |
| Pretax Income | n/a |
| Net Income | -38.03M |
| EBITDA | 8.48M |
| EBIT | 7.34M |
| Loss Per Share | -$5.30 |
Full Income StatementBalance Sheet
The company has $8.50 million in cash and $27.96 million in debt, giving a net cash position of -$19.46 million or -$2.27 per share.
| Cash & Cash Equivalents | 8.50M |
| Total Debt | 27.96M |
| Net Cash | -19.46M |
| Net Cash Per Share | -$2.27 |
| Equity (Book Value) | -14.78M |
| Book Value Per Share | -1.72 |
| Working Capital | -26.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.50 million and capital expenditures -$1.61 million, giving a free cash flow of -$106,000.
| Operating Cash Flow | 1.50M |
| Capital Expenditures | -1.61M |
| Free Cash Flow | -106,000 |
| FCF Per Share | -$0.01 |
Full Cash Flow StatementMargins
Gross margin is 77.69%, with operating and profit margins of 18.72% and -97.02%.
| Gross Margin | 77.69% |
| Operating Margin | 18.72% |
| Pretax Margin | -96.96% |
| Profit Margin | -97.02% |
| EBITDA Margin | 21.63% |
| EBIT Margin | 18.72% |
| FCF Margin | n/a |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -146.84% |
| Shareholder Yield | -146.84% |
| Earnings Yield | -11.55% |
| FCF Yield | -0.03% |
Analyst Forecast
The average price target for SANUWAVE Health is $49.00, which is 30.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.00 |
| Price Target Difference | 30.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
SANUWAVE Health has an Altman Z-Score of -7.8 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.8 |
| Piotroski F-Score | 6 |
